Pages that link to "Q47571316"
Jump to navigation
Jump to search
The following pages link to Cost and Resource Use of Pemphigus and Pemphigoid Disorders Pre- and Post-Rituximab (Q47571316):
Displaying 2 items.
- Shifting Focus in the Therapeutics of Immunobullous Disease (Q33737974) (← links)
- First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial (Q38876705) (← links)